InMode rises after announcing it is evaluating strategic alternatives
02/02/2026 12:18
** U.S.-listed shares of Israel-based medical technology firm InMode INMD.O rise 3.5% to $16.26 premarket
** Co says it is currently evaluating potential strategic alternatives
** Says it is aware of reports related to the publicly announced non-binding proposal by Steel Partners Holdings L.P. to acquire 51% of INMD
** Adds committee of independent directors it had previously established to oversee this review process will continue to evaluate any matters presented to it
** INMD fell 12% in 2025
(Reporting by Sneha S K)
((Sneha.SK@thomsonreuters.com))
Recent news on InMode
See all newsBrief: Inmode Haifa District Court Denied Sp Strategic Holdings' Request For Temporary Injunctive Relief In Its Entirety
InMode Ltd. reports results for the quarter ended June 30 - Earnings Summary
Brief: Inmode Q2 Revenue USD 95.589 Million Versus. Ibes Estimate USD 93 Million
InMode Q2 revenue beats estimates on steady U.S. demand
Brief: Steel Partners Urges Inmode Shareholders To Vote Against The Re-Election Of Dr. Hadar Ron And Against Extraordinary Special Committee Compensation At The July 30 Annual General Meeting